COVID-19 Vaccine FDA Pharmaceutical Industry 
HIT Consultant
MAY 2, 2022
The FDA is attempting to address this, having issued guidelines related to diversity in clinical trials in November 2020 – perhaps prompted by widespread media coverage of the fact that the black members of the society and other people of color were underrepresented in clinical trials for COVID-19 vaccines.
HIT Consultant
AUGUST 18, 2021
The pandemic has given rise to new norms in drug development that will influence the future of the industry as we know it. The world has been in urgent need of COVID-19 vaccines, treatments, and diagnostic tools. Since March 2020, the FDA has issued 72 new COVID-specific guidance documents and is likely to continue.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Dot Compliance
FEBRUARY 1, 2022
The global pharmaceutical industry has seen its share of challenges in recent years, from manufacturing and supply chain bottlenecks to growing demand for faster delivery of drugs to the marketplace. The next evolution is for companies to implement Industry 4.0 What will the near future bring to the table? References.
Bill of Health
SEPTEMBER 28, 2023
Despite having an outsized role in the discovery, development, manufacturing, and procurement of COVID-19 vaccines, therapeutics, and diagnostics, the federal government has generally not exercised any leverage in ensuring fair pricing and affordable access to these essential medical products.
Hall Render
FEBRUARY 18, 2022
CMS may now enforce its COVID-19 vaccination policy for healthcare workers in all 50 states. CMS responds to states seeking vaccination mandate waivers. Federal vaccination mandate begins for healthcare workers in 24 states. Meet new FDA chief Dr. Robert Califf: 5 things to know. The future St. has a name.
Expert insights. Personalized for you.
98 
Let's personalize your content